Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/BAFNAPH stock hub

NSE/BAFNAPH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/BAFNAPHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.1B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/BAFNAPH

In the news

Latest news · NSE/BAFNAPH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E32.3

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC9.2

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/BAFNAPH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

INR

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	406
Employees Change	43%
Employees Change Percent	11.85
Enterprise value	INR 3.4B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE878I01022
Last refreshed	2026-05-10
Market cap	INR 3.1B
Price	INR 132
Price currency	INR
Rev Per Employee	3,631,480.3x
Sector	Healthcare
Sic	2834
Symbol	nse/BAFNAPH
Website	https://www.bafnapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.09%
EV Earnings	35.65x
EV/EBIT	30.22x
EV/EBITDA	21.25x
EV/Sales	2.34x
P/B ratio	3.42x
P/E ratio	32.29x
P/S ratio	2.12x
PE Ratio3 Y	119.19x
PE Ratio5 Y	92.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.73%
EBITDA Margin	10.99%
Gross margin	32.37%
Gross Profit	INR 477.3M
Gross Profit Growth	10.65%
Gross Profit Growth Q	15.23%
Gross Profit Growth3 Y	17.21%
Gross Profit Growth5 Y	14.24%
Net Income	INR 96.6M
Net Income Growth	124.83%
Net Income Growth Q	93.83%
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Net Income Growth3 Y	24.96%
Net Income Growth5 Y	33.21%
Pretax Margin	6.55%
Profit Margin	6.55%
Profit Per Employee	INR 237,963
Profitable Years	5
Roa5y	4.4
Roe5y	10.18
ROIC	9.24
Roic5y	9.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	79.49%
Cagr3y	17.87%
Cagr5y	-2.15%
EPS Growth	125.1
EPS Growth Q	95
EPS Growth Quarters	3
EPS Growth Years	0
EPS Growth3 Y	24.59
EPS Growth5 Y	33.28
Revenue Growth	-0.51x
Revenue Growth Q	15.36x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	18.73x
Revenue Growth5 Y	18.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 2.5M
Debt	INR 324M
Debt EBITDA	INR 2
Debt Equity	INR 0.36
Equity	INR 912.3M
Interest Coverage	3.47
Net Cash	INR -321.5M
Net Cash By Market Cap	INR -10.3
Net Debt EBITDA	INR 1.98
Net Debt Equity	INR 0.35
Tangible Book Value	INR 912.3M
Tangible Book Value Per Share	INR 38.54
WACC	5.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	79.42%
200-day SMA	129
3Y total return	63.77%
50-day SMA	120.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-10.3%
All Time High	233.6
All Time High Change	-43.48%
All Time High Date	2020-12-18
All Time Low	4.4
All Time Low Change	2,900%
All Time Low Date	2020-03-02
ATR	6.56
Beta	0.18
Beta1y	0.58
Beta2y	0.73
Ch YTD	-12.42
High	132
High52	202.1
High52 Date	2025-11-12
High52ch	-34.67%
Low	131
Low52	71.57
Low52 Date	2025-05-09
Low52ch	84.44%
Ma50ch	9.59%
Price vs 200-day SMA	2.29%
RSI	53.75
RSI Monthly	57.13
RSI Weekly	51.9
Sharpe ratio	1.28x
Sortino ratio	2.33
Total Return	0.14%
Tr YTD	-12.42
Tr1m	15.59%
Tr1w	-2.17%
Tr3m	13.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 114M
Operating Income Growth	112.9
Operating Income Growth Q	5.29
Operating Income Growth3 Y	66.66
Operating Income Growth5 Y	10.55
Operating margin	7.73

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,341,356%
Shares Insiders	4.97%
Shares Institutions	4.36%
Shares Out	23,656,335
Shares Qo Q	-0.52%
Shares Yo Y	-0.14%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	4,269.45x
Bv Per Share	38.54
Ch1m	15.59
Ch1w	-2.17
Ch1y	79.42
Ch3m	13.79
Ch3y	63.77
Ch5y	-10.3
Ch6m	-24.38
Change	0.59%
Change From Open	0
Close	131.2
Days Gap	0.59
Depreciation Amortization	48,104,250
Dollar Volume	82,896
Earnings Date	2026-05-26
EBIT	INR 114M
EBITDA	INR 162.1M
EPS	INR 4.09
F Score	2
Fiscal Year End	March
Founded	1,981
Graham Number	59.53156
Graham Upside	-54.9
Is Primary Listing	1
Last Earnings Date	2026-02-11
Last Report Date	2025-12-31
Lynch Fair Value	INR 102
Lynch Upside	-22.59
Ma150	137.4
Ma150ch	-3.92%
Ma20	134.4
Ma20ch	-1.77%
Next Earnings Date	2026-05-26
Open	132
Position In Range	100
Price Date	2026-05-08
Price EBITDA	INR 19.27
Ptbv Ratio	3.42
Relative Volume	0.15x
Revenue	1,474,381,000x
Tr6m	-24.38%
Volume	628

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/BAFNAPH pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/BAFNAPH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/BAFNAPH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.4%

Share of float held by funds and institutions

Insider ownership

+5.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

NSE/BAFNAPH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.8

Neutral momentum band

Price vs 200-day MA

+2.3%

50/200-day relationship not available

Beta (5Y)

0.18

Less volatile than the market

Sharpe ratio

1.28

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/BAFNAPH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/BAFNAPH stock rating?

nse/BAFNAPH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/BAFNAPH analysis?

The full report lives at /stocks/nse/BAFNAPH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/BAFNAPH?

The latest report frames nse/BAFNAPH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/BAFNAPH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.